c-myb and Mml 1,2 and 3 continue to be the focus of the laboratory since we have found that these loci are important to the development of promonocytic leukemia. These are targets of insertional mutagenesis by retroviruses in our animal model. In addition, this year we have found new proviral insertion sites called Mml4 and 5.Our laboratory has shown that the c-myb oncogene, which encodes a transcription factor, can be activated in promonocytic leukemias when the retrovirus integrates into the locus. Previously, we characterized the many ways this gene can be activated by retroviral insertion and the mechanistic consequences of this integration. Recently, a major goal has been to characterize the functional role of this transcription factor in leukemic cells. In particular, we are interested in identifying target genes regulated by this transcription factor that are involved in proliferation and anti- apoptotic processess. This year we have continued studies which have show that c-myc is an important target through which the c-Myb protein exerts its positive effect on proliferation. Using both a Myb-estrogen receptor fusion protein and a dominant negative Myb-estrogen receptor protein, both of which can be induced rapidly by tamoxifen, we have demonstrated that c-Myb regulates c-myc at the transcriptional level. These data were confirmed using conditional induction of c-myb gene transcription via a vector with a metallothionein promoter. Our studies on targets are being extended in two ways. First, we are looking for new target genes of c-Myb using microarray technology and second, we are looking for genes that are regulated by a related gene B-Myb. Candidate targets have already been identified. We discovered that the loci Mml1,Mml2 and Mml3 are individually associated with the development of a subset of acute monocytic leukemias and all three map to the same region on chromosome 10. Although they are connected on the same BAC clone they are separated from each other by greater than 20 kb. Presently, a major focus of the laboratory is the characterization of transcripts from these loci that may encode a new proto-oncogene or tumor suppressor gene. Greater than 60 kb of this region have been sequenced resulting in the finding of several homologous ESTs which have been useful in the identification of genes encoded by this region. We are presently determining if any of these genes is altered in its transcription due to integration of proviruses in general region. In addition, we identifed through the use of retroviral insertional mutagenesis, two other apparently novel loci Mml4 and Mml5 that are located on chromosomes other than chromosome 10. On of this has been mapped to chromosome 13. - animal model, c-myb, Insertional Mutagenesis, Leukemia, proteolysis, retrovirus, - Neither Human Subjects nor Human Tissues

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC008952-13
Application #
6289224
Study Section
Special Emphasis Panel (LCO)
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Wolff, Linda; Bies, Juraj (2013) p15Ink4b Functions in determining hematopoietic cell fates: Implications for its role as a tumor suppressor. Blood Cells Mol Dis 50:227-31
Slape, Christopher; Hartung, Helge; Lin, Ying-Wei et al. (2007) Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation. Cancer Res 67:5148-55
Rosu-Myles, Michael; Taylor, Barbara J; Wolff, Linda (2007) Loss of the tumor suppressor p15Ink4b enhances myeloid progenitor formation from common myeloid progenitors. Exp Hematol 35:394-406
Markus, Jan; Garin, Matthew T; Bies, Juraj et al. (2007) Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16). Cancer Res 67:992-1000
Wolff, Linda; Ackerman, Steven J; Nucifora, Giuseppina (2005) Meeting report: Sixth International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia, Annapolis, May 1-4, 2005. Exp Hematol 33:1436-42
Schmidt, M; Nazarov, V; Stevens, L et al. (2000) Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis. Mol Cell Biol 20:1970-81
Bies, J; Feikova, S; Bottaro, D P et al. (2000) Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases. Oncogene 19:2846-54
Feikova, S; Wolff, L; Bies, J (2000) Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells. Neoplasma 47:212-8
Bies, J; Nazarov, V; Wolff, L (1999) Alteration of proteolytic processing of c-Myb as a consequence of its truncation in murine myeloid leukemia. Leukemia 13 Suppl 1:S116-7
Bies, J; Nazarov, V; Wolff, L (1999) Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias. J Virol 73:2038-44